Shanghai, August 6, 2025 — Agilent Technologies Inc. (NYSE: A) and Abiochem Biotechnology (Group) Co., Ltd. ("Abiochem") today inaugurated the "Joint Innovation Laboratory for Synthetic Biology" at Abiochem's R&D center. The ceremony was attended by Ding Hao, Agilent Assistant Vice President and General Manager of Biopharma Business & East China Instrument Sales, and Qu Xudong, Co-founder of Abiochem, leading executive delegations from both parties.

The laboratory will leverage complementary strengths to advance high-throughput synthetic biology design/screening platforms, optimize quality control for biosynthetic processes, and co-develop application cases with published outcomes to accelerate industry innovation.

As a synthetic biology leader, Abiochem focuses on industrial applications across biopharma, green agriculture, and nutrition. Its breakthroughs include pioneering China approvals for functional ingredients like HMOs, steviol glycosides, and sialic acid. Abiochem maintains strategic partnerships with global industry giants.

Technology Integration
Abiochem currently utilizes Agilent's HPLC, UHPLC-QTOF, and UHPLC-QQQ systems. Building on existing collaboration in process control, impurity identification, and genotoxicity testing, the new lab will focus on:

• High-throughput testing
• Metabolic pathway analysis
• AI-driven automated analytics 

to scale synthetic biology applications.

Executive Perspectives

Ding Hao, Agilent:
"Synthetic biology is a core engine for future industries. Abiochem’s industrial expertise synergizes with Agilent's disciplinary excellence. This lab is not just a technical hub but an innovation testbed to bridge R&D and industrialization."

Qu Xudong, Abiochem:
"Agilent's analytical leadership will empower our R&D efficiency. Together we'll deliver benchmark solutions for biopharma and green agriculture, accelerating lab-to-scale translation of synthetic biology."

Agilent's Strategic Commitment
Agilent prioritizes synthetic biology with integrated platforms spanning genomics, chromatography, mass spectrometry, microbial cell analysis, and automation. Through localized innovation, Agilent provides customized solutions for China's green bio-manufacturing sector.